4.5. Deterioration of LV Systolic Function
cardiac dysfunction
Significant cancer-therapy-related cardiac dysfunction (defined as a 10% reduction in LV ejection fraction, with values less than 50%) is rare with modern anthracycline doses, with a 1–2% prevalence [